Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
Kolijn, Detmar, Pabel, Steffen, Tian, Yanna, Lódi, Mária, Herwig, Melissa, Carrizzo, Albino, Zhazykbayeva, Saltanat, Kovács, Ãrpád, Fülöp, Gábor Ã, Falcão-Pires, Inês, Reusch, Peter H, VanJournal:
Cardiovascular Research
DOI:
10.1093/cvr/cvaa123
Date:
May, 2020
File:
PDF, 1.13 MB
2020
File converter
More search results
More benefits 
